Center for Scientific Review; Notice of Closed Meetings, 74026 [05-24012]
Download as PDF
<![CDATA[
74026
Federal Register / Vol. 70, No. 239 / Wednesday, December 14, 2005 / Notices
Dated: December 7, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–24014 Filed 12–13–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Hematopoietic Stem Cells.
Date: December 19, 2005.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Delia Tang, MD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802,
Bethesda, MD 20892, 301–435–2506,
tangd@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Neuro
Genetics.
Date: December 20, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Robert C. Elliott, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
VerDate Aug<31>2005
15:29 Dec 13, 2005
Jkt 208001
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 7, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–24012 Filed 12–13–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
Center for the Evaluation of Risks to
Human Reproduction (CERHR);
Extension of the Public Comment
Period on the Di-(2Ethylhexyl)Phthalate (DEHP) Update
Expert Panel Report
National Institute for
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
ACTION: Extension of public comment
period.
AGENCY:
SUMMARY: The CERHR announces a 30day extension of the public comment
period on the DEHP update expert panel
report. The CERHR previously
announced a public comment period on
the DEHP update expert panel report in
a prior Federal Register Notice
[November 16, 2005 (Vol. 70, No. 220,
pg. 69567)]. The DEHP update expert
panel report was released by CERHR on
November 21, 2005 and public
comments will now be accepted by
CERHR through Friday, February 3,
2006 instead of the original deadline of
January 4, 2006. The DEHP update
expert panel report is available from the
CERHR Web site (https://
cerhr.niehs.nih.gov) or in print from the
CERHR (see ADDRESSES below).
DATES: The final DEHP update expert
panel report is available for public
comment. Written public comments on
this report should be received by
February 3, 2006.
ADDRESSES: Comments on the expert
panel report and any other
correspondence should be sent to Dr.
Michael D. Shelby, CERHR Director,
NIEHS, P.O. Box 12233, MD EC–32,
Research Triangle Park, NC 27709
(mail), (919) 316–4511 (fax), or
shelby@niehs.nih.gov (e-mail). Courier
address: CERHR, 79 T.W. Alexander
Drive, Building 4401, Room 103,
Research Triangle Park, NC 27709.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
Background Information on the CERHR
The NTP established the CERHR in
June 1998 [Federal Register, December
14, 1998 (Vol. 63, No. 239, pp. 68782)].
The CERHR is a publicly accessible
resource for information about adverse
reproductive and/or developmental
health effects associated with exposure
to environmental and/or occupational
exposures. Expert panels conduct
scientific evaluations of agents selected
by the CERHR in public forums.
The CERHR invites the nomination of
agents for review or scientists for its
expert registry. Information about
CERHR and the nomination process can
be obtained from its Web site (https://
cerhr.niehs.nih.gov) or by contacting Dr.
Shelby (see ADDRESSES above). The
CERHR selects chemicals for evaluation
based upon several factors including
production volume, potential for human
exposure from use and occurrence in
the environment, extent of public
concern, and extent of data from
reproductive and developmental
toxicity studies.
The CERHR follows a formal, multistep process for review and evaluation
of selected chemicals. The formal
evaluation process was published in the
Federal Register notice July 16, 2001
(Vol. 66, No. 136, pp. 37047–37048) and
is available on the CERHR Web site
under ‘‘About CERHR’’ or in printed
copy from the CERHR.
Dated: December 5, 2005.
Samuel H. Wilson,
Deputy Director, National Institute of
Environmental Health Sciences.
[FR Doc. E5–7290 Filed 12–13–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
Agency Information Collection
Activities: Comment Request
60-Day notice of information
collection under review: Immigrant
Petition by Alien Entrepreneur, Form I–
526, 1615–0026.
ACTION:
The Department of Homeland
Security, U.S. Citizenship and
Immigration Services (USCIS) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection is
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 70, Number 239 (Wednesday, December 14, 2005)]
[Notices]
[Page 74026]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24012]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Hematopoietic Stem Cells.
Date: December 19, 2005.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Delia Tang, MD, Scientific Review Administrator,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, 301-435-
2506, tangd@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neuro Genetics.
Date: December 20, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Robert C. Elliott, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892, 301-435-3009, elliotro@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 7, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-24012 Filed 12-13-05; 8:45 am]
BILLING CODE 4140-01-M
